Celon Pharma
CLN.WA
#7081
Rank
$0.37 B
Marketcap
$6.90
Share price
1.65%
Change (1 day)
91.71%
Change (1 year)

P/S ratio for Celon Pharma (CLN.WA)

P/S ratio as of November 2024 (TTM): 8.82

According to Celon Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.25. At the end of 2024 the company had a P/S ratio of 4.72.

P/S ratio history for Celon Pharma from 2017 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20244.72-7.33%
20235.0912.31%
20224.53-48.92%
20218.87-35.56%
202013.8-22.05%
201917.761.69%
201810.9-31.59%
201716.0